CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Robotic therapyWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D020521 Stroke NIH 0.32

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0001297 Stroke HPO 0.32

There is one clinical trial.

Clinical Trials


1 Upper Limb Robotic Rehabilitation in Stroke Survivors Using a Portable Device During the COVID-19 Outbreak. A Feasibility Study

The COVID-19 outbreak requires a rapid re-shaping of the entire organization of the rehabilitation services. This includes the design and planning of appropriate rehabilitation settings, intervention and logistics for organizing space for patients. The aims of this study are: (a) to evaluate the feasibility of the bedside use of a novel rehabilitation device for upper limb in patients with stroke; (b) to evaluate the motor and cognitive outcomes of the treatment; (c) to validate the instrumental outcomes provided by the device.

NCT04392453 Stroke Device: Robotic therapy
MeSH:Stroke
HPO:Stroke

Primary Outcomes

Description: It is a tool for measuring the usability

Measure: System Usability Scale (SUS)

Time: After 30 rehabilitation sessions

Description: It is a tool for measuring the acceptability.

Measure: Technology Acceptance Model (TAM)

Time: After 30 rehabilitation sessions

Description: It is a tool for measuring the satisfaction.

Measure: Likert Scale

Time: After 30 rehabilitation sessions

Secondary Outcomes

Description: The Fugl-Meyer Assessment is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, sensation and joint functioning in patients with post-stroke hemiplegia. It is applied clinically and in research to determine disease severity, describe motor recovery, and to plan and assess treatment.

Measure: Fugl-Meyer Assessment for upper extremity (FMA-UE)

Time: At baseline; after 30 rehabilitation sessions

Description: It is a clinical instrument for characterizing the strength of the paretic upper extremity following stroke.

Measure: Motricity Index for the upper extremity (MI-UE)

Time: At baseline; after 30 rehabilitation sessions

Description: It is a clinical instrument for characterizing upper limb spasticity. Shoulder, elbow and wrist spasticity will be assessed.

Measure: Modified Ashworth Scale (MAS)

Time: At baseline; after 30 session rehabilitation sessions

Description: It is a unidimensional measure of pain intensity in adults.

Measure: Numeric Pain Rating Scale (NPRS)

Time: At baseline; after 30 rehabilitation sessions

Description: It is a measure of independence in activities of daily living.

Measure: Modified Barthel Index (mBI)

Time: At baseline; after 30 rehabilitation sessions

Description: It is a widely used screening assessment for detecting cognitive impairment.

Measure: Montreal Cognitive Assessment (MoCA)

Time: At baseline; after 30 rehabilitation sessions

Description: The kinematics of the end-effector of the robot will be acquired during point-to-point tasks.

Measure: Kinematic parameters

Time: At baseline (twice, one day apart); after 10 rehabilitation sessions; after 20 rehabilitation sessions; after 30 rehabilitation sessions


Related HPO nodes (Using clinical trials)